✦ LIBER ✦

Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease

✍ Scribed by Jeremy M. Van Raamsdonk; Jacqueline Pearson; Daniel A. Rogers; Ge Lu; Vilte E. Barakauskas; Alasdair M. Barr; William G. Honer; Michael R. Hayden; Blair R. Leavitt

Book ID: 116458601
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 286 KB
Volume: 196
Category: Article
ISSN: 0014-4886
DOI: 10.1016/j.expneurol.2005.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cystamine treatment is neuroprotective i

Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease

✍ Jeremy M. Van Raamsdonk; Jacqueline Pearson; Craig D. C. Bailey; Daniel A. Roger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Striosome-matrix pathology and motor def

Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease

✍ Collene Lawhorn; Diane M. Smith; Lucy L. Brown 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Wild-type huntingtin ameliorates striata

Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease

✍ Jeremy M Van Raamsdonk; Jacqueline Pearson; Zoe Murphy; Michael R Hayden; Blair 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 345 KB

Gabapentin-lactam, but not gabapentin, r

Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington’s disease

✍ Birgit Zucker; Dagmar E. Ludin; Thomas A. Gerds; Carl H. Lücking; G. Bernhard La 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 293 KB

Atypical diabetes associated with inclus

Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington’s disease is not improved by treatment with hypoglycaemic agents

✍ Mark J. Hunt; A. Jennifer Morton 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 420 KB